Solid Biosciences (SLDB) News Today $4.85 -0.46 (-8.66%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period FY2024 EPS Estimate for Solid Biosciences Lowered by AnalystNovember 15 at 1:35 AM | americanbankingnews.comWhat is Chardan Capital's Estimate for SLDB FY2024 Earnings?Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at Chardan Capital reduced their FY2024 earnings per share estimates for shares of Solid Biosciences in a report released on Monday, November 11th. Chardan Capital analyst Y. Livshits now anticipates that the company will postNovember 14 at 8:35 AM | marketbeat.comSolid Biosciences to Present at the Jefferies London Healthcare ConferenceNovember 14 at 8:00 AM | globenewswire.comSolid Biosciences price target lowered to $12 from $15 at JPMorganNovember 13, 2024 | markets.businessinsider.comJPMorgan Chase & Co. Lowers Solid Biosciences (NASDAQ:SLDB) Price Target to $12.00JPMorgan Chase & Co. decreased their target price on shares of Solid Biosciences from $15.00 to $12.00 and set an "overweight" rating for the company in a research report on Tuesday.November 12, 2024 | marketbeat.comSolid Biosciences to participates in a conference call hosted by JPMorganNovember 12, 2024 | markets.businessinsider.comHC Wainwright Cuts Earnings Estimates for Solid BiosciencesNovember 12, 2024 | americanbankingnews.comFY2024 EPS Forecast for Solid Biosciences Reduced by AnalystSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at HC Wainwright dropped their FY2024 earnings per share estimates for Solid Biosciences in a report issued on Thursday, November 7th. HC Wainwright analyst A. He now anticipates that the company will post earnings per share oNovember 11, 2024 | marketbeat.comFY2024 Earnings Estimate for SLDB Issued By Leerink PartnrsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Equities researchers at Leerink Partnrs dropped their FY2024 earnings per share (EPS) estimates for Solid Biosciences in a research report issued to clients and investors on Wednesday, November 6th. Leerink Partnrs analyst J. Schwartz now anticNovember 11, 2024 | marketbeat.comWhat is William Blair's Estimate for SLDB FY2024 Earnings?Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Equities researchers at William Blair reduced their FY2024 earnings per share estimates for shares of Solid Biosciences in a note issued to investors on Wednesday, November 6th. William Blair analyst S. Corwin now expects that the company willNovember 11, 2024 | marketbeat.comBrokerages Set Solid Biosciences Inc. (NASDAQ:SLDB) Target Price at $15.67November 11, 2024 | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Privia Health Group (PRVA) and Jazz Pharmaceuticals (JAZZ)November 9, 2024 | markets.businessinsider.comStrategic Advancements and Optimized Approaches Drive Buy Rating for Solid BiosciencesNovember 9, 2024 | markets.businessinsider.comWe're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn RateNovember 9, 2024 | finance.yahoo.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Average Rating of "Buy" from AnalystsShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given a consensus recommendation of "Buy" by the eight brokerages that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating and two have issued a strong buy rating on the cNovember 8, 2024 | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Solid Biosciences (SLDB)November 7, 2024 | markets.businessinsider.comSolid Biosciences’ Strategic Advances and Clinical Trial Progress Drive Buy RatingNovember 7, 2024 | markets.businessinsider.comSolid Biosciences' (SLDB) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $16.00 price target on shares of Solid Biosciences in a research note on Thursday.November 7, 2024 | marketbeat.comSolid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 6, 2024 | globenewswire.comSolid Biosciences to Participate at the Truist Securities BioPharma SymposiumOctober 31, 2024 | markets.businessinsider.comSolid Biosciences: Buy Rating Reaffirmed Amid Market Skepticism and Upcoming SGT-003 Data ReleaseOctober 26, 2024 | markets.businessinsider.comInsider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) Insider Sells 2,923 Shares of StockOctober 23, 2024 | insidertrades.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Average Recommendation of "Buy" from AnalystsShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given a consensus recommendation of "Buy" by the eight analysts that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and two have given a stOctober 14, 2024 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Shares Purchased by Millennium Management LLCMillennium Management LLC boosted its stake in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 135.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,728,065 shares of the company's stock after acquiOctober 9, 2024 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comSolid Biosciences (SLDB) Gets a Buy from Piper SandlerOctober 6, 2024 | markets.businessinsider.comMarshall Wace LLP Takes $1.55 Million Position in Solid Biosciences Inc. (NASDAQ:SLDB)Marshall Wace LLP purchased a new position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 274,005 shares of the company's stock, valued at approximately $1,554,000. MaOctober 6, 2024 | marketbeat.com112,776 Shares in Solid Biosciences Inc. (NASDAQ:SLDB) Purchased by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new stake in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 112,776 shares of the company's stock, valued at approximately $639,000. Point72 Asset MOctober 5, 2024 | marketbeat.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2024 | globenewswire.comDeerfield Management Company L.P. Series C Sells 517,000 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Deerfield Management Company L.P. Series C decreased its position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 22.9% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,743,398 shares of the company's stock after selling 517,000September 26, 2024 | marketbeat.comSolid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines ConferenceSeptember 23, 2024 | markets.businessinsider.comAcadian Asset Management LLC Takes $379,000 Position in Solid Biosciences Inc. (NASDAQ:SLDB)Acadian Asset Management LLC purchased a new position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 67,073 shares of the company's stocSeptember 20, 2024 | marketbeat.comiTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market SessionSeptember 16, 2024 | benzinga.comSolid Biosciences to Participate at the 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 4, 2024 | globenewswire.comFY2024 Earnings Estimate for Solid Biosciences Inc. (NASDAQ:SLDB) Issued By Cantor FitzgeraldSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2024 earnings per share (EPS) estimates for shares of Solid Biosciences in a report issued on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the company will earAugust 26, 2024 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) to Post FY2024 Earnings of ($2.72) Per Share, Chardan Capital ForecastsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Stock analysts at Chardan Capital issued their FY2024 earnings estimates for shares of Solid Biosciences in a research report issued to clients and investors on Monday, August 19th. Chardan Capital analyst Y. Livshits anticipates that the compaAugust 22, 2024 | marketbeat.comSolid Biosciences Inc. Expected to Earn FY2026 Earnings of ($2.87) Per Share (NASDAQ:SLDB)Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Investment analysts at Leerink Partnrs issued their FY2026 earnings estimates for shares of Solid Biosciences in a report issued on Wednesday, August 14th. Leerink Partnrs analyst J. Schwartz expects that the company will post earnings per sharAugust 16, 2024 | marketbeat.com3 Best Stocks to Buy Now, 8/14/2024, According to Top AnalystsAugust 14, 2024 | msn.comBuy Rating Affirmed for Solid Biosciences Amid Promising Early Data on SGT-003 DMD TherapyAugust 14, 2024 | markets.businessinsider.comSolid Biosciences (NASDAQ:SLDB) Issues Quarterly Earnings ResultsSolid Biosciences (NASDAQ:SLDB - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.61) EPS for the quarter, beating analysts' consensus estimates of ($0.66) by $0.05.August 14, 2024 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) PT Lowered to $15.00 at BarclaysBarclays lowered their price objective on shares of Solid Biosciences from $18.00 to $15.00 and set an "overweight" rating on the stock in a research report on Wednesday.August 14, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Solid Biosciences (NASDAQ:SLDB)HC Wainwright reaffirmed a "buy" rating and issued a $16.00 price target on shares of Solid Biosciences in a report on Wednesday.August 14, 2024 | marketbeat.comSLDB Stock Earnings: Solid Biosciences Beats EPS for Q2 2024August 13, 2024 | investorplace.comSolid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business UpdatesAugust 13, 2024 | globenewswire.comVanguard Group Inc. Purchases 920,404 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Vanguard Group Inc. lifted its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 283.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,244,575 shares of the company's stock after acquiring an additional 920,404 shares during theAugust 13, 2024 | marketbeat.comPiper Sandler Keeps Their Buy Rating on Solid Biosciences (SLDB)August 10, 2024 | markets.businessinsider.comJanus Henderson Group PLC Takes $23.94 Million Position in Solid Biosciences Inc. (NASDAQ:SLDB)Janus Henderson Group PLC acquired a new stake in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,808,440 shares of the company's stock,August 1, 2024 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have earned a consensus recommendation of "Buy" from the nine ratings firms that are presently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy recommendation and one has issuedJuly 31, 2024 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest UpdateSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 1,660,000 shares, a drop of 45.6% from the June 30th total of 3,050,000 shares. Based on an average trading volume of 451,600 shares, the short-interest ratio is presently 3.7 days. Currently, 5.2% of the company's shares are short sold.July 26, 2024 | marketbeat.com Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! SLDB Media Mentions By Week SLDB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLDB News Sentiment▼-0.060.55▲Average Medical News Sentiment SLDB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLDB Articles This Week▼262▲SLDB Articles Average Week Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Champions Oncology News Today 89bio News Today Prothena News Today Pliant Therapeutics News Today Autolus Therapeutics News Today Tyra Biosciences News Today Cronos Group News Today Dianthus Therapeutics News Today Rapport Therapeutics News Today Neurogene News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLDB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLDB Stock Alerts